•  
  •  
  •  
  •  

2025-11-27 02:14:19

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Lenskart Partners with Labubu Maker Popmart's Sweet Bean to Launch a Limited-Edition Collection on 4 Dec in Singapore
  • Salasar Techno Engineering Ltd bags two contracts worth Rs. 695.18 crores
  • Indo-Tech Transformers Ltd receives order worth Rs. 91.26 crores
  • Kesar India Ltd acquires Plot at Nagpur, Maharashtra having Revenue potential of Rs. 900 Crore
  • BOBCARD LIMITED Launches Cashback Credit Card, Promising 'Happy Returns' on Every Spend

Keywords Selected:  Phase2

Stock Report

  • Hi-Tech Pipes Commences Commercial Production at Sanand, Gujarat - Unit II - Phase II
  • Powering Growth: Rushil Décor Commences Trial RunProduction at Phase 2 of its State-of-the-Art JumboLaminate Plant
  • XTGlobal announces Phase II Enhancement and Modernization Project Award from U.S. Integrated Healthcare Organization
  • Interarch commissions New Box Column Line in Uttarakhand and commissions Phase 2 of its Andhra Pradesh Unit for Pre-Engineered Steel Buildings
  • Sai Life Sciences completes Phase II of Production Block 11 at Bidar, India, expands capacity to 700 KL
  • Suven Life Sciences announces First Patient Randomized in Phase-2b Clinical Trial of Ropanicant
  • Heranba Organics Pvt Ltd commences Commercial Production at its Sarigam Unit, Phase-II
  • Tata Steel inaugurates Phase II expansion of Kalinganagar operations
  • Max Estates achieves pre-sales booking value of INR 845 Crores within a week of the launch of Phase II of Estate 128 project in Noida
  • Interarch to Expand Installed Capacity with Phase 2 Andhra Pradesh Unit and Kichha Plant Upgrade, Strengthens R&D Initiatives
  • NTPC Ltd board approves investment for Telangana Super Thermal Power Project, Phase 2
  • Zydus and ICMR initiate a Phase 2 proof-of-concept trial of Desidustat in patients with Sickle Cell Disease
  • Suven Life Sciences to Present Positive Results from Phase-2a Proof-of-Concept Study of Ropanicant
  • Birla Estates sets a remarkable precedent in Bengaluru with a booking value of about Rs. 600 crore for Birla Trimaya Phase 2
  • Tata Steel commissions India's largest blast furnace at Kalinganagar
  • Suven Life Sciences Announces Positive Topline Results from Phase-2a Proof-of-Concept Signal Detection Open Label Study of Ropanicant
  • Max House - Phase 2 Achieves 100% Occupancy in less than a year of its completion
  • Zydus Lifesciences announces completion of Phase II(a) clinical trial of Usnoflast
  • Sun Pharma and Moebius Medical Ltd present Phase 2b study on MM-II
  • Suven Life Sciences to present Phase-2 Positive Results on Samelisant at American Academy of Neurology2024 Annual Meeting, Denver, USA
  • Lumax Industries Limited approves expansion projects
  • Zydus receives approval from USFDA to initiate Phase II clinical trial of ZYIL1 in patients with Parkinson's disease
  • Max Estates receives Completion Cum Occupancy Certificate for Phase 2 of Max House, a boutique office campus, in Okhla, South Delhi
  • Ultramarine Specialty Chemicals Ltd commissions pigments project phase-2

Latest Post

  • Lenskart Partners with Labubu Maker Popmart's Sweet Bean to Launch a Limited-Edition Collection on 4 Dec in Singapore
  • Salasar Techno Engineering Ltd bags two contracts worth Rs. 695.18 crores
  • Indo-Tech Transformers Ltd receives order worth Rs. 91.26 crores
  • Kesar India Ltd acquires Plot at Nagpur, Maharashtra having Revenue potential of Rs. 900 Crore
  • BOBCARD LIMITED Launches Cashback Credit Card, Promising 'Happy Returns' on Every Spend


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024